🔎 Trials Near Me

Home › Rectal Cancer › Illinois

Pag-aaral pangklinika para sa Rectal Cancer sa Illinois

12 pag-aaral para sa Rectal Cancer ang naghahanap ng mga kalahok sa mga site sa Illinois.

Mga Lungsod sa Illinois

Opisyal na teksto ng pag-aaral (English)

PRE-ISPY Phase I/II Oncology Platform Program

  • The University of Chicago Medicine Comprehensive Cancer Center, Chicago
  • UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, New Lenox
  • UChicago Medicine Orland Park, Orland Park
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05868226

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

  • Endeavor Health ( Site 2027), Evanston
  • Accellacare of Duly ( Site 2015), Lisle
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06997497

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

  • OSF Saint Anthony's Health Center, Alton
  • Illinois CancerCare-Bloomington, Bloomington
  • Illinois CancerCare-Canton, Canton
  • at 31 pa
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07283939

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

  • OSF Saint Anthony's Health Center, Alton
  • John H Stroger Jr Hospital of Cook County, Chicago
  • Loyola University Medical Center, Maywood
  • at 3 pa
Nagre-recruit
Edad 45 hanggang 70 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05080673

Family Communications After Genetic Testing

  • OSF Saint Anthony's Health Center, Alton
  • Illinois CancerCare-Bloomington, Bloomington
  • Illinois CancerCare-Canton, Canton
  • at 33 pa
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07143487

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

  • Rush-Copley Medical Center, Aurora
  • Northwestern University, Chicago
  • Carle at The Riverfront, Danville
  • at 6 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT06205485

Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3

  • City of Hope at Illinois Chicago Downtown, Chicago
  • City of Hope at Chicago, Zion
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT07595874

Integrated Cancer Repository for Cancer Research

  • Rush-Copley Cancer Care Center, Aurora
  • Rush-Copley Healthcare Center, Yorkville
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer

  • The University of Chicago, Chicago
Nagre-recruit
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT05943210

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

  • Illinois Cancer Specialists, Arlington Heights
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT07011576

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

  • Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 49 · Lahat ng kasarian · Na-update Abr 24, 2026 · NCT05732623

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Chicago
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.